Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-21-023273
Filing Date
2021-11-15
Accepted
2021-11-15 07:30:52
Documents
9
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 6-K cybininc-form6xk1112workiv.htm 6-K 16639
2 EX-99.1 cybinincfs-q2x22xsept30202.htm EX-99.1 511179
3 EX-99.2 cybin-mdaq2xseptember30202.htm EX-99.2 811903
4 EX-99.3 q22021-cfocertificatecybin.htm EX-99.3 13182
5 EX-99.4 q22021-ceocertificatecybin.htm EX-99.4 13527
6 EX-99.5 pressreleasereq2financialr.htm EX-99.5 28125
7 capturea.jpg GRAPHIC 29252
8 capture.jpg GRAPHIC 29252
9 image_0a.jpg GRAPHIC 21213
  Complete submission text file 0001628280-21-023273.txt   1494871
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40673 | Film No.: 211406336
SIC: 2834 Pharmaceutical Preparations